DAIC

JANUARY 31, 2024

milla1cf Wed, 01/31/2024 - 17:10 January 31, 2024 — Royal Philips , a global leader in health technology, announced that its latest TEE transducer, designed to serve more patients with improved overall comfort, has received FDA 510(k) clearance. In structural heart disease, the quality of a 3D TEE image can help save lives.

Ultrasound 111

Ultrasound Technology Innovation Heart Valves 111

DAIC

MARCH 11, 2024

a med tech company dedicated to helping patients with persistent ischemic heart disease, has announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain. T45 Labs is a specialized medical technology innovation company located in Santa Clara, Silicon Valley, CA.

Angina 59

Angina Innovation Heart Disease Chest Pain 59

DAIC

JANUARY 17, 2024

With the continuous progress of science and technology, artificial intelligence (AI) has become an important driving force for a new round of scientific and technological revolution and industrial change. In recent years, the attempts of AI to run through the whole process of CCTA have expanded the application scope of CCTA.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

ADN Center of Excellence

NOVEMBER 14, 2024

Access to Cutting-Edge Techniques Many fellowships expose participants to the latest technologies and innovations in their field. These programs also prepare fellows for leadership roles, equipping them to drive change and innovation in their respective fields. When to Pursue a Fellowship? Here are some scenarios to consider: 1.

Academic 59

Academic Interventional Cardiology Private Practice Innovation 59

DAIC

JUNE 27, 2024

Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics.

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

DAIC

JULY 15, 2024

He added, “Adding Story Health to our ecosystem both allows providers to exceed their care quality goals and ensures patients aren’t waiting to receive ongoing care, especially between visits when they may have higher disease burden or complications that can lead to expensive emergency department visits.

Technology 105

Technology Innovation Nursing Heart Failure 105

DAIC

JULY 12, 2024

Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.

Outcomes 122

Outcomes Hospital Research Innovation 122

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. The DynamX bioadaptor has a novel design and mechanism of action designed to return the diseased vessel to a more normal condition, through three distinct phases.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

JANUARY 28, 2025

The clipping spline (mesh) is defined by the control points (green) and provides a smooth cutaway view into the looping embryonic mouse heart, revealing the blood flow (orange and blue) in the hearts atrium and ventricle. Faubert and Shang Wang, Stevens Institute of Technology tim.hodson Tue, 01/28/2025 - 10:45 Jan.

Research 52

Research Congenital Technology Congenital Heart Disease 52

GEMMS

APRIL 3, 2025

As patient expectations rise and technology advances, engaging patients effectively has never been more crucial to delivering top-tier care. GEMMS is committed to enhancing patient care through innovative solutions that improve engagement, streamline workflows, and support cardiovascular care. GEMMS ONE V7.8,

Technology 52

Technology Patient Care Education Innovation 52

DAIC

JUNE 4, 2024

This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.

Ultrasound 111

Ultrasound Education Research Technology 111

Circulation: Cardiovascular Interventions

JANUARY 23, 2024

BACKGROUND:Current metrics used to adjust for case mix complexity in congenital cardiac catheterization are becoming outdated due to the introduction of novel procedures, innovative technologies, and expanding patient subgroups. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pediatrics 40

GEMMS

MAY 22, 2024

Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. These algorithms, trained on large datasets, recognize patterns and features associated with heart diseases.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Cardiometabolic Health Congress

OCTOBER 10, 2024

These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

DAIC

FEBRUARY 13, 2024

Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2023 Dec 12:jead339.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

CardiacWire

APRIL 10, 2024

Interventional Innovations – Interventional cardiology was the clear winner at ACC24, with numerous trials supporting an expanded role for interventional procedures across a wider range of conditions than we ever could have imagined five years ago.

Innovation 59

Innovation Technology Interventional Cardiology Medicare 59

Wellnest

JULY 18, 2023

Here, we will delve into the fascinating evolution of ECG technology, exploring its origins, key milestones, and modern applications. It was in 1901 that people got aware when Willem Einthoven, a Dutch physiologist, developed the string galvanometer, a device capable of recording electrical signals from the heart with remarkable precision.

Electrocardiogram 52

Electrocardiogram Technology Innovation Heart Rhythm 52

DAIC

JANUARY 3, 2024

Since its inception, HeartFlow has been committed to building a new standard of care for people at risk of heart disease. For over a decade, HeartFlow’s deep partnerships with more than 1,000 hospitals globally, including 80% of the top 50 heart hospitals in the U.S., Arbab-Zadeh, Heart Int 2012. Yokota, et al.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

Wellnest

JUNE 19, 2023

India is witnessing a rise in Coronary heart disease (CHD). By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

DAIC

APRIL 5, 2024

For nearly two decades, CRF has led the way in pioneering transcatheter therapies for structural heart disease at TVT. New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions.

Research 52

Research Heart Disease Best Practices Education 52

DAIC

APRIL 5, 2024

For nearly two decades, CRF has led the way in pioneering transcatheter therapies for structural heart disease at TVT. New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions.

Heart Disease 52

Heart Disease Best Practices Education Tricuspid 52

SoftCath

JUNE 20, 2021

The acceleration in technological innovation has brought a significant transformation in the medical device industry. Emerging Trends of Medical Imaging in the Healthcare Sector Chronic diseases are thriving expeditiously. Identify accumulated blood clots that can result in heart diseases, cancer, or emphysema.

Technology 52

Technology Cancer COVID-19 Blood Clot 52

ADN Center of Excellence

OCTOBER 7, 2024

Interventional cardiology has dramatically evolved over the past decades, introducing advanced techniques and tools that have revolutionized the treatment of coronary artery disease, valvular disorders, and structural heart diseases.

Interventional Cardiology 59

Interventional Cardiology Coronary Artery Disease Innovation Anatomy 59

DAIC

DECEMBER 19, 2023

“Optimal treatment of cardiovascular disease requires clinicians to address critical co-morbid conditions such as sleep apnea,” said Nicholas Skipitaris, M.D. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression. billion (2).

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

GEMMS

AUGUST 29, 2024

These technologies are not just reshaping but also empowering how cardiology practices manage operations, deliver care, and enhance patient outcomes. These technologies are reshaping how cardiology practices manage operations, deliver care, and enhance patient outcomes.

Technology 52

Technology Patient Care Outcomes Coronary Artery Disease 52

CineECG

MAY 22, 2023

Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patient care. As ECG Excellence we are proud our CineECG technology was part of this innovation festival. HRS 2023 is a wrap!

Technology 52

Technology Atrial Fibrillation Anatomy Innovation 52

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

ADN Center of Excellence

OCTOBER 7, 2024

Interventional cardiology has dramatically evolved over the past decades, introducing advanced techniques and tools that have revolutionized the treatment of coronary artery disease, valvular disorders, and structural heart diseases.

Interventional Cardiology 52

Interventional Cardiology Coronary Artery Disease Innovation Anatomy 52

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

MARCH 21, 2024

To this end, ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services.

Pediatrics 86

Pediatrics Outcomes Patient Care TAVR 86

Cardiometabolic Health Congress

AUGUST 2, 2023

Dr. Caballero is an endocrinologist, clinical investigator, and faculty director of International Innovation and Diabetes Education at Harvard Medical School. These conditions affect a patient’s risk of health conditions like heart disease, diabetes, and obesity.

Education 40

Education Health Disparities Webinar Diabetes 40

DAIC

APRIL 1, 2024

Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

JANUARY 22, 2024

These are true innovators who propose novel approaches to major research challenges in the areas of heart disease, stroke and brain health. Loscalzo’s research will focus on the link between heart disease and certain foods, or chemicals naturally contained in foods. Tsao , Ph.D.,

Heart Disease 105

Heart Disease Research Aneurysm Cardiovascular Disease 105

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. With this investment, we look forward to helping Cleerly expand its reach and impact, bringing this potentially life-saving innovation to more patients and health systems nationally.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

DAIC

MAY 14, 2024

The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians. Medis Medical Imaging has been developing innovative post-processing software for the quantification of cardiovascular images for thirty-five years.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

JANUARY 16, 2024

Getty Images milla1cf Tue, 01/16/2024 - 14:11 January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same accuracy as a cardiologist, according to new research demonstrating how sophisticated deep learning technology can be applied to this disease of inequity.

Heart Disease 105

Heart Disease Ultrasound Technology Echocardiogram 105

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105